Company Search:
Advanced Search
Sponsored Links
Biosynex SA Company Snapshot
Biosynex SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other companies in this sector in FRANCE : Dbv Technologies (2019 sales of 13.14 million Euro [US$14.33 million] of which 100% was research and development of epicutaneous), Eurobio Scientific SA (59.10 million Euro [US$64.45 million] ), and Biocorp Sa (8.45 million Euro [US$9.21 million] ).

Sales Analysis. During the year ended December of 2019, sales at Biosynex SA were 34.23 million Euro (US$37.33 million). This is an increase of 9.7% versus 2018, when the company's sales were 31.21 million Euro. This was the fifth consecutive year of sales increases at Biosynex SA (and since 2014, sales have increased a total of 740%). Sales of Services saw an increase that was more than double the company's growth rate: sales were up 325.8% in 2019, from 281,328.00 Euro to 1.20 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biosynex SA
  Stock Performance Chart for Biosynex SA
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 12.60
(Figures in Euros )
1 Week 14.5%   13 Weeks -10.0%  
4 Weeks 306.5%   52 Weeks 358.2%  
Biosynex SA Key Data:
  Ticker: ALBIO Country: France
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 34,230,162
(Year Ending Jan 2020).
Employees: 144
  Currency: Euros Market Cap: 115,106,645
  Fiscal Yr Ends: December Shares Outstanding: 9,135,448
  Share Type: Actions Ordinaires Closely Held Shares: 4,644,473
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.